25871-1-AP

antibody from Proteintech Group

Targeting: PGR NR3C3, PR

ELISA (Data presented on provider website)

Immunocytochemistry (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

25871-1-AP

Provider

Proteintech Group

Product name

PR antibody

Antibody type

Polyclonal

Description

PR antibody (Cat. #25871-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IF, IHC,ELISA.

Reactivity

Human, Mouse

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

Upregulation of estrogen receptor alpha (ERα) expression in transgenic mice expressing human CYP4Z1.

Khayeka-Wandabwa C, Zhao J, Pathak JL, Wu H, Bureik M
Breast cancer research and treatment 2022 Jan;191(2):319-326

---

Pan-Cancer Prognostic Role and Targeting Potential of the Estrogen-Progesterone Axis.

Shen YT, Huang X, Zhang G, Jiang B, Li CJ, Wu ZS
Frontiers in oncology 2021;11:636365

---

The Possibility of Analyzing Endometrial Receptivity Using Cells from Embryo Transfer Catheters.

Goto K, Kawano Y, Utsunomiya T, Narahara H
Reproductive sciences (Thousand Oaks, Calif.) 2021 Sep;28(9):2623-2629

---

ZNF598 co-translationally titrates poly(GR) protein implicated in the pathogenesis of C9ORF72-associated ALS/FTD.

Park J, Lee J, Kim JH, Lee J, Park H, Lim C
Nucleic acids research 2021 Nov 8;49(19):11294-11311

---

Expression of hormone receptors predicts survival and platinum sensitivity of high-grade serous ovarian cancer.

Tan J, Song C, Wang D, Hu Y, Liu D, Ma D, Gao Q
Bioscience reports 2021 May 28;41(5)

---

Bushen Huoxue recipe attenuates early pregnancy loss via activating endometrial COX2-PGE2 angiogenic signaling in mice.

Song Y, Zhou F, Tan X, Liu X, Ding J, Zhang C, Li F, Zhu W, Ma W, Hu R, Zhang M
BMC complementary medicine and therapies 2021 Jan 14;21(1):36

---

Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistance.

Deng Y, Xia X, Zhao Y, Zhao Z, Martinez C, Yin W, Yao J, Hang Q, Wu W, Zhang J, Yu Y, Xia W, Yao F, Zhao D, Sun Y, Ying H, Hung MC, Ma L
Nature communications 2021 Dec 6;12(1):7041

---

G-Protein-Coupled Estrogen Receptor 1 Promotes Gender Disparities in Hepatocellular Carcinoma via Modulation of SIN1 and mTOR Complex 2 Activity.

Feng G, Cai J, Huang Y, Zhu X, Gong B, Yang Z, Yan C, Hu Z, Yang L, Wang Z
Molecular cancer research : MCR 2020 Dec;18(12):1863-1875

---

BML-111 inhibits EMT, migration and metastasis of TAMs-stimulated triple-negative breast cancer cells via ILK pathway.

Lin L, Luo X, Wang L, Xu F, He Y, Wang Q, Yuan C, Xu J, Yan L, Hao H
International immunopharmacology 2020 Aug;85:106625

---

Increased prevalence of granulovacuolar degeneration in C9orf72 mutation.

Riku Y, Duyckaerts C, Boluda S, Plu I, Le Ber I, Millecamps S, Salachas F, Brainbank NeuroCEB Neuropathology Network., Yoshida M, Ando T, Katsuno M, Sobue G, Seilhean D
Acta neuropathologica 2019 Nov;138(5):783-793